You may qualify if:
- You are aged 18 years or older
- You have been diagnosed as having Fabry disease
- You are male
The STAAR study has been designed to investigate the potential of an investigational gene therapy called ST-920 to treat men living with Fabry disease.
The site you are entering is not the property of, nor managed by, Sangamo Therapeutics. Sangamo Therapeutics assumes no responsibility for the content of sites not managed by Sangamo Therapeutics. Furthermore, Sangamo Therapeutics is not responsible for, nor does it have control over, the privacy policies of these sites.